Gross tumor volume margin and local control in p16-positive oropharynx cancer patients treated with intensity modulated proton therapy.
29/02/2024
/
Publications
This is a retrospective analysis of patients with p16+ OPC treated with IMPT. Sixty patients were included for analysis with a median follow-up of 17 months...
Osteoradionecrosis of the Jaw Following Proton Radiation Therapy for Patients With Head and Neck Cancer.
29/02/2024
/
Publications
Published in JAMA, this study reported the prevalence and clinical characteristics of ORN in patients with oral and oropharyngeal cancer (OOPC) treated with PRT...
Plan Creation, Evaluation, and Implementation of ConformalFLASH®
15/07/2021
/
Webinar
/
FLASH Therapy
What are the advantages of FLASH therapy? Where do we stand in FLASH therapy treatment planning?
Watch this webinar to understand the latest developments in...
Acute radiation dermatitis among patients with nasopharyngeal carcinoma treated with proton beam therapy: Prognostic factors and treatment outcomes.
29/02/2024
/
Publications
This study reported incidence of acute radiation dermatitis (ARD) of 57 NPC patients treated with PBT. The maximum ARD grade was 1, 2, and 3 in 26 (45.6%), 24...
Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma.
01/03/2024
/
Publications
This study analyzed 242 patients treated with PT-ReRT. Median follow-up was 12.0 months for all patients and 24.5 months for living patients. Median PT-ReRT...
High-Risk Non-Small Cell Lung Cancer Treated With Active Scanning Proton Beam Radiation Therapy and Immunotherapy.
01/03/2024
/
Publications
This study reported results of PBS-PT (60 GyRBE in 30 fractions) and immunotherapy for 29 patients with locally advanced (stage IIB to IIIC, 90%) high-risk...
Definitive intensity modulated proton re-irradiation for lung cancer in the immunotherapy era.
01/03/2024
/
Publications
This study reported results in 22 patients with recurrent NSCLC received IMPT reirradiation to a total mean dose of 60GyE. The first course of radiation was 60...
Clinical outcomes and factors involved in the local control of proton beam therapy for oligometastatic liver tumors in patients with colorectal cancer.
01/03/2024
/
Publications
This study reported outcomes of 41 patients with colorectal cancer liver metastases (63 lesions) treated with PBT to a total dose of 72.6 GyRBE in 22 fractions...
Reconstructive complications and early toxicity in breast cancer patients treated with proton-based postmastectomy radiation therapy.
01/03/2024
/
Publications
This study compared acute toxicities and reconstructive complications in patients treated with proton-based (n = 11)and photon-based PMRT (n = 26). Grade 2 skin...
Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial.
01/03/2024
/
Publications
The same study as above also reported results of QoL and patient-reported outcomes. QoL status was markedly impaired at baseline but significantly (p = 0.036)...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.